Anti-HIV-1-MN gp120 Recombinant Antibody (F58) (CAT#: MRO-121LC)

This product is a recombinant mouse anti-HIV-1-MN monoclonal antibody. F58 specifically binds to gp120 and can be potentially used in the treatment of acquired immunodeficiency syndrome (AIDS), a condition in humans characterized by clinical features including wasting syndromes, central nervous system degeneration and profound immunosuppression that results in life-threatening opportunistic infections and malignancies.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
Neut

Figure 1. Neutralization of HIV-1 IIIB by alanine-substituted F58 MicroAb.

Figure 1. Neutralization of HIV-1 IIIB by alanine-substituted F58 MicroAb.

Virus incubated with each MicroAb for 1 h at 37 6C was inoculated on to C8166 cells to determine the reduction in virus infectivity.

Heap, C. J., Wang, Y., Pinheiro, T. J., Reading, S. A., Jennings, K. R., & Dimmock, N. J. (2005). Analysis of a 17-amino acid residue, virus-neutralizing microantibody. Journal of general virology, 86(6), 1791-1800.

Neut

Figure 2 graphically report the results of the screening by reverse transcriptase, p24, MT-2 and syncytia formation assays, respectively, of a monoclonal antibody of the invention for the ability to neutralize infection of H9 cells by live HIV-1 strains.

Figure 2 graphically report the results of the screening by reverse transcriptase, p24, MT-2 and syncytia formation assays, respectively, of a monoclonal antibody of the invention for the ability to neutralize infection of H9 cells by live HIV-1 strains.

Neut

Figure 3 graphically report the results of the screening by reverse transcriptase, p24, MT-2 and syncytia formation assays, respectively, of a monoclonal antibody of the invention for the ability to neutralize infection of H9 cells by live HIV-1 strains.

Figure 3 graphically report the results of the screening by reverse transcriptase, p24, MT-2 and syncytia formation assays, respectively, of a monoclonal antibody of the invention for the ability to neutralize infection of H9 cells by live HIV-1 strains.


Specifications

  • Immunogen
  • RP70
  • Host Species
  • Mouse
  • Type
  • Mouse antibody
  • Specificity
  • HIV-1-MN
  • Clone
  • F58
  • Applications
  • ELISA, Inhib
  • Related Disease
  • AIDS

Applications

  • Application Notes
  • The HIV-1-MN gp120 antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Inhibition.

Target

  • Alternative Names
  • Human immunodeficiency virus type 1 MN; HIV-1 MN; Envelope glycoprotein gp120; gp120; HIV envelope

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone F58"

See other products for "HIV-1-MN gp120"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-121LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare